Literature DB >> 26815107

Enterocutaneous fistulas: an overview.

J F Whelan1, R R Ivatury2.   

Abstract

Enterocutaneous fistulas remain a difficult management problem. The basis of management centers on the prevention and treatment of sepsis, control of fistula effluent, and fluid and nutritional support. Early surgery should be limited to abscess drainage and proximal defunctioning stoma formation. Definitive procedures for a persistent fistula are indicated in the late postoperative period, with resection of the fistula segment and reanastomosis of healthy bowel. Even more complex are the enteroatmospheric fistulas in the open abdomen. These enteric fistulas require the highest level of multidisciplinary approach for optimal outcomes.

Entities:  

Keywords:  Bowel fistulas; Enteric fistula; Enteroatmospheric fistula; Gastrointestinal fistula; Open abdomen

Year:  2011        PMID: 26815107     DOI: 10.1007/s00068-011-0097-2

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  16 in total

1.  MANAGEMENT OF INTESTINAL FISTULAS.

Authors:  R CHAPMAN; R FORAN; J E DUNPHY
Journal:  Am J Surg       Date:  1964-08       Impact factor: 2.565

Review 2.  Open abdomen after trauma and abdominal sepsis: a strategy for management.

Authors:  William P Schecter; Rao R Ivatury; Michael F Rotondo; Asher Hirshberg
Journal:  J Am Coll Surg       Date:  2006-09       Impact factor: 6.113

3.  Beaumont and St Martin: a blast from the past.

Authors:  I M Rutkow
Journal:  Arch Surg       Date:  1998-11

4.  Enterocutaneous fistula: are treatments improving?

Authors:  John M Draus; Sara A Huss; Niall J Harty; William G Cheadle; Gerald M Larson
Journal:  Surgery       Date:  2006-09-06       Impact factor: 3.982

5.  An 11-year experience of enterocutaneous fistula.

Authors:  P Hollington; J Mawdsley; W Lim; S M Gabe; A Forbes; A J Windsor
Journal:  Br J Surg       Date:  2004-12       Impact factor: 6.939

6.  A ten-year review of enterocutaneous fistulas after laparotomy for trauma.

Authors:  Peter E Fischer; Timothy C Fabian; Louis J Magnotti; Thomas J Schroeppel; Tiffany K Bee; George O Maish; Stephanie A Savage; Ashley E Laing; Andrew B Barker; Martin A Croce
Journal:  J Trauma       Date:  2009-11

7.  Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae.

Authors:  François Gayral; Jean-Pierre Campion; Jean-Marc Regimbeau; Joëlle Blumberg; Pascal Maisonobe; Philippe Topart; Philippe Wind
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

8.  Biological dressings for the management of enteric fistulas in the open abdomen: a preliminary report.

Authors:  Ramin Jamshidi; William P Schecter
Journal:  Arch Surg       Date:  2007-08

9.  Treatment of high output entero-cutaneous fistulae associated with large abdominal wall defects: single center experience.

Authors:  G Dionigi; R Dionigi; F Rovera; L Boni; P Padalino; G Minoja; S Cuffari; G Carrafiello
Journal:  Int J Surg       Date:  2007-08-02       Impact factor: 6.071

10.  Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes.

Authors:  Jose L Martinez; Enrique Luque-de-Leon; Juan Mier; Roberto Blanco-Benavides; Felipe Robledo
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

View more
  3 in total

1.  Nutritional Management in Enterocutaneous Fistula. What is the evidence?

Authors:  Manal Badrasawi; Suzana Shahar; Ismail Sagap
Journal:  Malays J Med Sci       Date:  2015 Jul-Aug

2.  Bletilla striata promotes the healing of enterocutaneous fistula: A case report.

Authors:  Hong Zhou; Yan Jin; Chen Gu; Yigang Chen; Jiazeng Xia
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Fasciocutaneous anterolateral thigh flaps for complex abdominal wall reconstruction after resection of enterocutaneous fistulas and the role of indocyanine green angiography: a pilot study.

Authors:  T Pruimboom; I B M Ploegmakers; E Bijkerk; S O Breukink; R R W J van der Hulst; S S Qiu
Journal:  Hernia       Date:  2020-03-26       Impact factor: 4.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.